intelliheart entry to europe

IM Medical’s Intelliheart testing system is being introduced to the health system in Italy
with an agreement for a pilot program at a major hospital in the province of Umbria.
The Italian agreement represents the first expansion of Intelliheart into the international
marketplace. It provides for hundreds of tests to be done over a period of two months in a
leading public hospital under the supervision of a prominent Italian cardiologist.
Data including ECGs will be transmitted online back to Melbourne for analysis, using
Intelliheart’s unique software system.
The program is being carried out at the Azienda Sanitaria Locale 1 Umbria (Hospital of
Citta Castello). It will be supervised by Dr Maurizio Cocchieri, Director of Cardiology.
The Chief Executive Officer of IM Medical Limited, Mr Tommas Bonvino, said: “The
Italian agreement is a milestone for the company. It proves there is great interest in our
technology in the big markets and gives the company great confidence as it rolls out its’
international marketing program.�
Mr Bonvino said the Umbrian program placed IM Medical in a good position to introduce
Intelliheart to other parts of the Italian health system and the wider EU market.
IM Medical Limited has been negotiating with providers and suppliers in several countries
since Intelliheart was boosted with the first stage of the integration of the Cardanal
technology in September and receipt of TGA and CE approvals.
Mr Bonvino said, in the European region, active discussions were under way in
Switzerland, Germany and other parts of Italy.
Intelliheart uses a series of tests to assess cardiac risk. The unique Cardanal technology,
acquired by IM Medical early this year, provides cardiologists with more sensitive and
reliable tools.